•  
  •  
  •  
  •  

2026-07-20 14:36:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • D. P. Abhushan Reports Strong Q1 FY27 Performance: Net Profit Surges 77% YoY to ₹64.45 Crore
  • Regency Fincorp Reports Outstanding Q1 FY27 Results: Net Profit Surges 98.9% Sequentially to ₹7.03 Crore
  • Vimta Labs Reports Strong Q1 FY27 Results: Net Profit Rises 11.4% YoY to ₹21.04 Crore
  • Grand Foundry Limited Reports Strong Turnaround in Q1 FY27: Net Profit Soars to ₹2.11 Crore
  • Mahindra Logistics Reports Robust Turnaround in Q1 FY27: Net Profit Reaches ₹27.83 Crore as Revenue Crosses ₹2,000 Crore

Keywords Selected:  LenalidomideCapsules

Stock Report

  • NATCO launches additional strengths for the Generic Version of Revlimid® in USA
  • Eugia Pharma Specialities Ltd receives USFDA final approval Lenalidomide Capsules
  • Zydus receives final approval from the USFDA for Lenalidomide Capsules, 2.5 mg and 20 mg
  • Zydus launches Lenalidomide Capsules
  • Zydus receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg
  • Dr. Reddy's Laboratories launches Lenalidomide Capsules in the U.S.
  • NATCO Launches First Generic Version of Revlimid® in the U.S. market
  • Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the USFDA

Latest Post

  • D. P. Abhushan Reports Strong Q1 FY27 Performance: Net Profit Surges 77% YoY to ₹64.45 Crore
  • Regency Fincorp Reports Outstanding Q1 FY27 Results: Net Profit Surges 98.9% Sequentially to ₹7.03 Crore
  • Vimta Labs Reports Strong Q1 FY27 Results: Net Profit Rises 11.4% YoY to ₹21.04 Crore
  • Grand Foundry Limited Reports Strong Turnaround in Q1 FY27: Net Profit Soars to ₹2.11 Crore
  • Mahindra Logistics Reports Robust Turnaround in Q1 FY27: Net Profit Reaches ₹27.83 Crore as Revenue Crosses ₹2,000 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025